Patents by Inventor Eva Chan

Eva Chan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8809622
    Abstract: The present invention relates to methods for identifying cucumber lines having increased resistance to Downy Mildew, and identification of genetic markers linked to gene(s) conditioning such increased disease resistance. The present invention also relates to methods of breeding cucumber plants from lines having increased Downy Mildew resistance by marker-assisted selection, compositions including nucleic acid probes or primers which are useful for such marker assisted selection, and plants and plant parts produced by such methods.
    Type: Grant
    Filed: October 22, 2010
    Date of Patent: August 19, 2014
    Assignee: Seminis Vegetable Seeds, Inc.
    Inventors: David Caldwell, Eva Chan, Jeroen de Vries, Tarek Joobeur, Joseph King, Antonio Reina, Nischit Shetty
  • Publication number: 20110126309
    Abstract: The present invention relates to methods for identifying cucumber lines having increased resistance to Downy Mildew, and identification of genetic markers linked to gene(s) conditioning such increased disease resistance. The present invention also relates to methods of breeding cucumber plants from lines having increased Downy Mildew resistance by marker-assisted selection, compositions including nucleic acid probes or primers which are useful for such marker assisted selection, and plants and plant parts produced by such methods.
    Type: Application
    Filed: October 22, 2010
    Publication date: May 26, 2011
    Inventors: David Caldwell, Eva Chan, Jeroen de Vries, Tarek Joobeur, Joseph King, Antonio Reina, Nischit Shetty
  • Publication number: 20090198618
    Abstract: Device, system, and method for loading, managing and using smartcard authentication token and digital certificates in e-commerce. System for making and accepting payments in on-line transaction between parties including transaction server coupled with storage device in which subscriber data structure is defined and stores transaction subscriber information and configured to communicate via network with certificate issuer and with card issuer. Computer implemented method for making and accepting payments in online transaction. Computer implemented method of issuing authentication certificate. Authentication token (smart card or SIM card) apparatus. Device for performing reading and/or writing operation to dual media smart card and SIM cards. Device, system, and method for using unique digital values to prevent fraudulent access or use of authentication token embedded with security digital certificate.
    Type: Application
    Filed: January 14, 2009
    Publication date: August 6, 2009
    Inventors: Yuen Wah Eva Chan, Henry Fung
  • Patent number: 6887675
    Abstract: The present invention is directed to novel polypeptides, nucleic acids and related molecules which have an effect on or are related to the cell cycle. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided by the present invention are methods for identifying novel compositions which mediate cell cycle bioactivity, and the use of such compositions in diagnosis and treatment of disease.
    Type: Grant
    Filed: April 25, 2001
    Date of Patent: May 3, 2005
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Ying Luo, Eva Chan, Xiang Xu, Betty Huang, Valeria Ossovskaya
  • Publication number: 20050074825
    Abstract: The present invention is directed to novel polypeptides, nucleic acids and related molecules which have an effect on or are related to the cell cycle. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided by the present invention are methods for identifying novel compositions which mediate cell cycle bioactivity, and the use of such compositions in diagnosis and treatment of disease.
    Type: Application
    Filed: July 8, 2003
    Publication date: April 7, 2005
    Inventors: Ying Luo, Eva Chan, Xiang Xu, Betty Huang, Valeria Ossovskaya
  • Patent number: 6617102
    Abstract: The present invention is directed to novel polypeptides, nucleic acids and related molecules which have an effect on or are related to the cell cycle. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided by the present invention are methods for identifying novel compositions which mediate cell cycle bioactivity, and the use of such compositions in diagnosis and treatment of disease.
    Type: Grant
    Filed: October 25, 2000
    Date of Patent: September 9, 2003
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Ying Luo, Eva Chan, Xiang Xu, Betty Huang, Valeria Ossovskaya
  • Patent number: 6589725
    Abstract: The present invention is directed to novel polypeptides, nucleic acids and related molecules which have an effect on or are related to the cell cycle. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided by the present invention are methods for identifying novel compositions which mediate cell cycle bioactivity, and the use of such compositions in diagnosis and treatment of disease.
    Type: Grant
    Filed: October 25, 1999
    Date of Patent: July 8, 2003
    Assignee: Rigel Pharmaceuticals, Inc.
    Inventors: Ying Luo, Eva Chan, Xiang Xu, Betty Huang